Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR.

Mazurov VI, Nasonov EL, Lila AM, Korolev MA, Prystrom AM, Kundzer EV, Soroka NF, Kastanayan AA, Povarova TV, Plaksina TV, Antipova OV, Krechikova DG, Smakotina SA, Tciupa OA, Puntus EV, Raskina TA, Shilova LN, Kropotina TV, Nesmeyanova OB, Popova TA, Vinogradova IB, Dokukina EA, Plotnikova AV, Pukhtinskaia PS, Zinkina-Orikhan AV, Linkova YN, Eremeeva AV, Lutckii AA.

Open source

DOI: 10.1134/s1607672924701072
Published: 2024-08-28
Container: Dokl Biochem Biophys
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1134/s1607672924701072,
  title = {Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR.},
  author = {Mazurov VI and  Nasonov EL and  Lila AM and  Korolev MA and  Prystrom AM and  Kundzer EV and  Soroka NF and  Kastanayan AA and  Povarova TV and  Plaksina TV and  Antipova OV and  Krechikova DG and  Smakotina SA and  Tciupa OA and  Puntus EV and  Raskina TA and  Shilova LN and  Kropotina TV and  Nesmeyanova OB and  Popova TA and  Vinogradova IB and  Dokukina EA and  Plotnikova AV and  Pukhtinskaia PS and  Zinkina-Orikhan AV and  Linkova YN and  Eremeeva AV and  Lutckii AA.},
  year = {2024},
  journal = {Dokl Biochem Biophys},
  doi = {10.1134/s1607672924701072},
  url = {https://doi.org/10.1134/s1607672924701072}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR.
AU  - Mazurov VI
AU  -  Nasonov EL
AU  -  Lila AM
AU  -  Korolev MA
AU  -  Prystrom AM
AU  -  Kundzer EV
AU  -  Soroka NF
AU  -  Kastanayan AA
AU  -  Povarova TV
AU  -  Plaksina TV
AU  -  Antipova OV
AU  -  Krechikova DG
AU  -  Smakotina SA
AU  -  Tciupa OA
AU  -  Puntus EV
AU  -  Raskina TA
AU  -  Shilova LN
AU  -  Kropotina TV
AU  -  Nesmeyanova OB
AU  -  Popova TA
AU  -  Vinogradova IB
AU  -  Dokukina EA
AU  -  Plotnikova AV
AU  -  Pukhtinskaia PS
AU  -  Zinkina-Orikhan AV
AU  -  Linkova YN
AU  -  Eremeeva AV
AU  -  Lutckii AA.
PY  - 2024
JO  - Dokl Biochem Biophys
DO  - 10.1134/s1607672924701072
UR  - https://doi.org/10.1134/s1607672924701072
ER  -

APA

VI, M., EL, N., AM, L., MA, K., AM, P., EV, K., NF, S., AA, K., TV, P., TV, P., OV, A., DG, K., SA, S., OA, T., EV, P., TA, R., LN, S., TV, K., OB, N., TA, P., IB, V., EA, D., AV, P., PS, P., AV, Z., YN, L., AV, E., & AA., L. (2024). Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR.. Dokl Biochem Biophys. https://doi.org/10.1134/s1607672924701072

Source records

europe-pmc · retrieved 2026-09-26T19:39:05.673Z